Search | Médecins Sans Frontières Access Campaign

20 results found
There are 2 active filters
Clear all filters
India
compulsory licence

20 results found

PEP Drugs for children at Angau Memorial General Hospital, Lae/ Morobe Province in Papua New Guinea. The MSF Family Support Centre provides medical and psychological services for survivors of child abuse, sexual and intimate partner violence. MSF started providing care at the centre in November 2007.

Press release |

23 March 2016

MSF welcomes Ministry of Commerce clarification on compulsory licensing: warns US pressure on India will continue

Tags Intellectual property and trade compulsory licence #HandsOffOurMeds India

Statement |

27 June 2013

Oral Testimony at US Congressional Hearing: “A Tangle of Trade Barriers: How India’s Industrial Policy is Hurting U.S. Companies.”

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines compulsory licencefree trade agreementuniversal access Novartis India

Speech |

02 May 2013

U.S. Penalises India for Promoting Access to Medicines Strategies by Placing it on Trade "Watch List"

Tags Intellectual property and trade antiretroviral medicines compulsory licence India

Opinion article |

28 March 2013

BBC: Do drugs really have to be so expensive?

Tags Intellectual property and tradeResearch and development compulsory licenceresearch and development (R&D) Bayer India

Statement |

04 March 2013

India upholds compulsory licence on cancer drug in Bayer case appeal

Tags Intellectual property and trade compulsory licence Bayer India

Statement |

18 January 2013

Final hearings begin in Bayer's appeal against Indian move to allow production of more affordable cancer drug

Tags Intellectual property and trade raltegravir compulsory licenceTRIPS Bayer India

Statement |

17 September 2012

MSF statement on India's dismissal of Bayer's request for a stay on compulsory licence

Tags Intellectual property and trade compulsory licence Bayer India

Statement |

05 September 2012

Bayer compulsory licence hearing concludes - judgment awaited

Tags Intellectual property and trade compulsory licence Bayer India

Press release |

03 September 2012

Bayer attempts block on affordable patented drugs in India

Tags Intellectual property and trade raltegravirantiretroviral medicines compulsory licence Bayer India

Feature story |

22 August 2012

Update: Intellectual Property Battles Continue in India; Novartis Trial Further Delayed

Tags HIV/AIDSIntellectual property and trade compulsory licence Bayer Novartis Drop the Case Campaign India

Statement |

21 August 2012

Bayer/Natco compulsory licence appeal – hearings postponed

Tags Intellectual property and trade HIV/AIDS compulsory licence Bayer India

Press release |

26 July 2012

Middle-Income Countries Flex Muscles to Overcome Patents in Face of Unaffordable Drug Prices

Tags HIV/AIDSIntellectual property and trade antiretroviral medicinesFDCs compulsory licence International AIDS Conference India

Feature story |

10 April 2012

Background Information on India's First Compulsory Licence

Tags Intellectual property and trade compulsory licence Bayer India

Tribal villagers wait for care at the MSF mobile Clinic in Jaigur, Dantewara district.

Press release |

12 March 2012

India Issues First Compulsory Licence

Tags HIV/AIDSIntellectual property and trade compulsory licenceTRIPS India

Opinion article |

22 November 2011

Trade and Public Health: a Decade of Double Standards

Tags Intellectual property and trade compulsory licenceDoha DeclarationTrans-Pacific Partnership Agreement (TPP)TRIPS Novartis Novartis Drop the Case Campaign IndiaThailand

Catherine Atieno lives with her family in Kibera, a deprived area of the Kenyan capital, Nairobi. Catherine is HIV positive and is being treated at an MSF clinic in Kibera where she also works as a cleaner and a cook. Seven years ago, after she had started antiretroviral treatment, Catherine documented her life in pictures in a project called ÔMy Life with HIVÕ.

Press release |

12 July 2011

Gilead Licence Expands Access, But Several Countries Left Out

Tags HIV/AIDS HIV/AIDS compulsory licencepatent pool Gilead BrazilIndiaThailand

Feature story |

01 July 2011

Major milestones in patents and access to medicines

Tags compulsory licenceDoha Declarationpatent poolTRIPS Novartis Drop the Case Campaign South AfricaIndiaThailand

Press release |

30 April 2010

U.S. Trade Watch List Threatens Access to Lifesaving Drugs

Tags Intellectual property and trade antiretroviral medicines compulsory licence BrazilIndiaThailand

Report |

16 January 2009

The Global Politics of Pharmaceutical Monopoly Power

Tags Intellectual property and tradeResearch and development compulsory licenceDoha Declarationfree trade agreementpatent poolTRIPS South AfricaIndia

India patent protest in 26 February 2005. Photograph by Shailly Gupta

02 January 2005

2005: India has to change its patent law

Tags antiretroviral medicines compulsory licence India

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

MSF welcomes Ministry of Commerce clarification on compulsory licensing: warns US pressure on India will continue

Oral Testimony at US Congressional Hearing: “A Tangle of Trade Barriers: How India’s Industrial Policy is Hurting U.S. Companies.”

U.S. Penalises India for Promoting Access to Medicines Strategies by Placing it on Trade "Watch List"

BBC: Do drugs really have to be so expensive?

India upholds compulsory licence on cancer drug in Bayer case appeal

Final hearings begin in Bayer's appeal against Indian move to allow production of more affordable cancer drug

MSF statement on India's dismissal of Bayer's request for a stay on compulsory licence

Bayer compulsory licence hearing concludes - judgment awaited

Bayer attempts block on affordable patented drugs in India

Update: Intellectual Property Battles Continue in India; Novartis Trial Further Delayed

Bayer/Natco compulsory licence appeal – hearings postponed

Middle-Income Countries Flex Muscles to Overcome Patents in Face of Unaffordable Drug Prices

Background Information on India's First Compulsory Licence

India Issues First Compulsory Licence

Trade and Public Health: a Decade of Double Standards

Gilead Licence Expands Access, But Several Countries Left Out

Major milestones in patents and access to medicines

U.S. Trade Watch List Threatens Access to Lifesaving Drugs

The Global Politics of Pharmaceutical Monopoly Power

2005: India has to change its patent law